2nd level presentation (1) (1)
TRANSCRIPT
Lin YangProfessor Peter Lipke’s Lab
Molecular, Cellular and Developmental Biology PhD programBrooklyn College
The City University of New York
The spatial-temporal distribution of amyloids in C. albicans biofilm
Outline • Background
• Aims of this proposal Rationale Preliminary data Experimental design
• Payoff
• Amyloids are cross beta-sheet structures formed by the assembly of a cluster of proteins or peptides.
• ways to detect amyloids:• amyloid binding dyes: Thioflavin T,
Thioflavin S, Congo Red.• electron microscopy• software algorithms: TANGO, Zipp
erDB• aggregation assay
Douglas M. Fowler et.al science direct (2007)
• Yeast cell adhesion molecules such as Als1p, Als5p of C. abicans and Flo1p, Muc1p of S. cerevisiae have functional amyloid forming sequences.
Ramsook CB et.al Eukaryotic Cell. 2010
Melissa Garcia et.al PLoS ONE (2011)
A biofilm is composed of cell aggregates, which are frequently embedded with extracellular matrix.
Jonathan S. Finkel & Aaron P. Mitchell Nature Reviews Microbiology (2011)
biofilm matrix
• Matrix components:• Mannoproteins• Carbohydrates• Lipids• eDNAs
Early, intermediate, mature phase of biofilm
Yeater et.al Microbiology (2007)
Melissa Garcia et.al PLoS ONE (2011)
Aim1: Anti-amyloids disrupt biofilm at early, intermediate and mature phase.Rationale
An Als anti-amyloid forming peptide (Als5pV326N) and high concentration of ThT inhibited biofilm formation at early phase.
D-amino acids causes the release of TasA amyloid fibers, which results in the disassembly of biofilm in Bacillus subtilis.
Figure 3. D-tyrosine causes the release of TasA fibers
Figure 2. D-amino acids break down pellicles.
Ilana Kolodkin-Gal et.al Sciece (2010)
An Als anti-amyloid forming peptide (Als5pV326N) inhibits the density of biofilm under fluid condition.
Cho Chan et.al Eukaryotic Cell (2014 )
Aim1: anti-amyloids disrupt biofilm at early, intermediate and mature phase.
• Preliminary data
ThT inhibited biofilm formation at early phase
Day185 4.5uM ThT 450uM ThT
A
B CCrystal Violet XTT assay
ThT inhibited biofilm at intermediate and mature phase
Rifamycin SV and Als5pV326N peptide released more yeast form cells from mature biofilm
Anti-amyloid Phase of biofilm affected Findings
Thioflavin T Early, Intermediate, Mature ThT caused the decrease of
biomass, metabolic rate of
biofilm at all phases. (XTT, Crystal
Violet data)
Als5 V326Npeptide Mature Als5 V326N peptide caused yeast
form cells release frommature
biofilm. (CFU calculation,microscopy)
Rifamycin SV Mature Rifamycin SV caused sparse
biofilm architecture and moreyeast form cells release at
mature phase.
Rifamycin SV and Als5pV326N peptide did not affect early and intermediate phase of biofilm based on XTT and Cyrstal violet assays.
Aim1: anti-amyloids disrupt biofilm at early, intermediate and mature phase.3. Experiments to do
• Test anti-amyloid property of rifamycin SV in C. albicans biofilm forming system: Dot blot using matrix sample extracted.
• Time course experiments to determine at which phase other amyloid binding dyes (ThS, Congo Red) affect biofilm (XTT, Crystal Violet, Microscopy)
• CFU calculation of cells released from mature biofilm upon treatment.
• Confocal microscopy: determine the architecture of biofilm upon treatment.
Aim 2: amyloids are in in vivo biofilm and are in the matrix of in vitro C. albicans biofilm.
• 1. Rationale:
Diego Romero et.al PNAS (2010)
2. Preliminary data
Aim 2: amyloids are in the biofilm matrix of C. albicans grown in vitro and in vivo. 3. Experiments to do
Table 1. A list of experiments to be applied in Aim 2 and expected resultsAssay Method Expected Result Controls
Extraction of SC 5314
biofilm matrix
Sonication,
centrifugation, dialysis,
lyophilization,
microscopyPi/Syto-9 Staining
Less than 5% of the
matrix is yeast cells
Intact cells
Detecting Als family
proteins in matrix
Dot blot, Als5p-biotin,
Avidin-HRP
Als family proteins are
in matrix sample
Als5 peptides,
Als5pV326N peptides
Staining proteins in the
matrix with ThT
fluorometer The fluorescence of ThT
increases after proteins
in the matrix is added.
ThT alone,
Als5 peptides,
Als5pV326N peptides
Discovery of amyloid
forming proteins in
matrix.
88% formic acid dissolves
matrix proteins, mass
spectrometry,TANGO/ZipperDB
algorithm
There are more proteins
that are found in ms
when the proteins aretreated with formic acid
than trypsin.
TANGO/ZipperDB
positive proteins are
found in formic acidtreated matrix.
Matrix sample
dissolved in trypsin.
In vivo biofilm staining ThT staining, confocal
microscopy
Biofilm grown on the
catheter is ThT positive
Empty catheter, in vivo
B. subtilis biofilm andtasA mutant biofilm
stained with ThT
Aim3: potential amyloid forming proteins are more highly expressed in biofilm than planktonic cell state.
• 1. Rationale
Chandra et.al Journal of Bacteriology 2001
Aim3: potential amyloid forming proteins are more highly expressed
in biofilm than planktonic cell state.
3. Experiments to doCandidate genes->proteins
•N-terminal signal peptide•GPI ancher •TANGO/ZipperDB
Proteins that meet all the requirements above are potential amyloid forming proteins
Compare with the list to see whether the potential amyloid forming proteins are more highly expressed in biofilm.
Yeater et.al Microbiology (2007)
Payoff• Aim 1 will determine when anti-amyloids affect biofilm in C.
albicans. (temporal)• Aim2 will confirm or deny whether amyloids are in C. albicans
biofilm matrix. (spatial)• Aim3 will determine whether amyloid forming proteins are biof
ilm spefic and when these proteins are differently expressed. (temporal)